Dapagliflozin for treating chronic kidney disease [ID6411]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 12 February 2025
Healthy.io test for home testing of urine albumin to creatinine ratioStatus:Topic selectionProgramme:Diagnostics guidanceExpected publication date: TBC
Irbesartan–propagermanium for treating focal segmental glomerulosclerosis in people 12 years and over having an angiotensin II receptor blocker TS ID 12000Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Obinutuzumab for treating lupus nephritis TID6420Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Sodium zirconium cyclosilicate for the first line treatment of hyperkalaemia [ID6439]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Sparsentan for treating primary IgA nephropathy [ID6308]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 30 April 2025
Vadadustat for treating symptomatic anaemia in adults having dialysis for chronic kidney disease [ID3821]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 20 November 2024